Tissue Kallikrein Mediates Pro-Inflammatory Pathways and Activation of Protease-Activated Receptor-4 in Proximal Tubular Epithelial Cells
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Tissue kallikrein (KLK1) expression is up-regulated in human diabetic kidney tissue and induced by high glucose (HG) in human proximal tubular epithelial cells (PTEC). Since the kallikrein-kinin system (KKS) has been linked to cellular inflammatory process in many diseases, it is likely that KLK1 expression may mediate the inflammatory process during the development of diabetic nephropathy. In this study, we explored the role of KLK1 in tubular pro-inflammatory responses under the diabetic milieu. Recombinant KLK1 stimulated the production of inflammatory cytokines in PTEC via the activation of p42/44 and p38 MAPK signaling pathways. Molecular knockdown of endogenous KLK1 expression by siRNA transfection in PTEC attenuated advanced glycation end-products (AGE)-induced IL-8 and ICAM-1 productions in vitro. Interestingly, exposure of PTEC to KLK1 induced the expression of protease-activated receptors (PARs). There was a 2.9-fold increase in PAR-4, 1.4-fold increase in PAR-1 and 1.2-fold increase in PAR-2 mRNA levels. Activation of PAR-4 by a selective agonist was found to elicit the pro-inflammatory and pro-fibrotic phenotypes in PTEC while blockade of the receptor by specific antagonist attenuated high glucose-induced IL-6, CCL-2, CTGF and collagen IV expression. Calcium mobilization by the PAR-4 agonist in PTEC was desensitized by pretreatment with KLK1. Consistent with these in vitro findings, there was a markedly up-regulation of tubular PAR-4 expression in human diabetic renal cortical tissues. Together, these results suggest that up-regulation of KLK1 in tubular epithelial cells may mediate pro-inflammatory pathway and PAR activation during diabetic nephropathy and provide a new therapeutic target for further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A previous study suggested that Klk1 may induce inflammatory cytokines in human RTECs, at least in vitro [37].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [37]
In the citing paper
“Additionally, Klk1 activates protease-activated receptors (PAR) such as PAR4 to trigger the release of inflammatory mediators from RTEC [37].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [37]
In the citing paper
“Klk1-mediated activation of PAR4 induces cytokine production and prevents apoptosis in RTEC, known as the bradykinin-independent pathway [37].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioregulation of kinins: kallikreins, kininogens, and kininases.
Bhoola, K. D., Figueroa, C. D., & Worthy, K. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00058-4 · Cited by 1,744 · cited 1×
“In most studies, KLK1 targets B2R via the formation of bradykinin (BK) [49] and we previously demonstrated this phenomenon in HG stimulated PTEC [9] although KLK1 was recently shown to directly activate B2R in the absence of kininogen both in vitro [50] and in vivo [51] in other cell types.”
BackgroundCellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Protease-Activated Receptors: Contribution to Physiology and Disease
OSSOVSKAYA, V. S., & BUNNETT, N. W. (2004) · Physiological Reviews · doi:10.1152/physrev.00028.2003 · Cited by 1,078 · cited 3×
“The increased PAR-4 expression after KLK1 incubation is consistent with the irreversible nature of PAR activation, in which the activating protease cleaves the extracellular N terminus to expose the tethered ligand, such that a fresh supply of the receptor is required to sustain the action of its agonist [20].”
BackgroundInflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072 · cited 2×
“Increased production of reactive oxygen species, pro-inflammatory cytokines and growth factors by resident and infiltrating cells are associated with the development of tubulointerstitial lesions in both clinical and experimental models of DN [3,4,34].”
BackgroundThe Role of Inflammatory Cytokines in Diabetic Nephropathy
Navarro-González, J. F., & Mora-Fernández, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 932 · cited 2×
“Inflammatory cytokines, mainly interleukin 1(IL-1), interleukin 6 (IL-6), interleukin 8 (IL-8) and tumor necrosis factor a (TNFa) are involved in the development of and progression to interstitial fibrosis in both diabetic patients and experimental models [4,5].”
BackgroundDiverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
Lan, H. Y. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1056 · Cited by 652 · cited 1×
“In addition to cytokine production, induction of growth factors, such as insulin-like growth factor 1 (IGF-1), hepatocyte growth factor (HGF), transforming growth factor b (TGFb) and connective tissue growth factor (CTGF) in proximal tubules enhances the activation and proliferation of myofibroblasts and collagen depo…”
BackgroundSelf-citationThe proximal tubule in the pathophysiology of the diabetic kidney
Vallon, V. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00809.2010 · Cited by 395 · cited 1×
“Tubulointerstitial inflammation is a critical process in the development of diabetic nephropathy [1,3,5].”
BackgroundPatel, V., Li, L., Cobo-Stark, P., Shao, X., Somlo, S., Lin, F., & Igarashi, P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn045 · Cited by 327 · cited 1×
“induced diabetic mice [35], the role of KKS in inflammatory pathways leading to DN is still controversial.”
BackgroundChung, A. C. K., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050510 · Cited by 268 · cited 1×
“Up-regulation of intercellular adhesion molecule 1 (ICAM-1) and chemokine (C-C motif) ligand 2 (CCL-2) leads to inflammatory cell recruitment and activation in the diabetic kidney [6].”
BackgroundSelf-citationImpaired Tubular Uptake Explains Albuminuria in Early Diabetic Nephropathy
Russo, L. M., Sandoval, R. M., Campos, S. B., Molitoris, B. A., Comper, W. D., & Brown, D. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050503 · Cited by 261 · cited 1×
“tubules have been identified to be responsible for the change in urinary albumin excretion, which is independent of glomerular permeability changes during the very early stage of DN [13].”
Background
Research works printed but not linked: 1
- Tang SC, Chan LY, Leung JC, Cheng AS, Lan HY, et al.. (2011) Additive renoprotective effects of B2-kinin receptor blocker and PPAR-gamma agonist in uninephrectomized db/db mice. Lab Invest. 21537328 · DOI
Cited by
Innate immunity in diabetic kidney disease
Tang, S. C. W., & Yiu, W. H. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0234-4 · Cited by 596
Self-citationKallikreins – The melting pot of activity and function
Kalinska, M., Meyer-Hoffert, U., Kantyka, T., & Potempa, J. (2016) · Biochimie · doi:10.1016/j.biochi.2015.09.023 · Cited by 125
Magliocca, G., Mone, P., Iorio, B. R. D., Heidland, A., & Marzocco, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105354 · Cited by 138
Gut microbial metabolites SCFAs and chronic kidney disease
Meng, H., Wei, W., Zhang, Y., Xiang, Z., Peng, D., Kasimumali, A., & Rong, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04974-6 · Cited by 128
“…a downstream inflammatory cascade [62], activating the transcription factors NF-κB, AP-1, and p53, and promoting pro-inflammatory cytokine and chemokine production [63–65], further exacerbating the inflammatory state and promoting the disease progression of CKD [66] and renal fibrosis [67].”
BackgroundYiu, W. H., Wong, D. W. L., Wu, H., Li, R. X., Yam, I., Chan, L. Y. Y., Leung, J. C. K., Lan, H. Y., Lai, K. N., & Tang, S. C. W. (2015) · Kidney International · doi:10.1038/ki.2015.331 · Cited by 104
Self-citationOe, Y., Hayashi, S., Fushima, T., Sato, E., Kisu, K., Satō, H., Ito, S., & Takahashi, N. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307883 · Cited by 95
“Interestingly, immunoreactive PAR2, but not PAR1, was higher in biopsy specimens from patients with DN than in specimens from patients without DN.(30) These results support the importance of PAR2 in the pathogenesis of DN.”
ResultInvolvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes
Stefanini, A. C. B., da Cunha, B. R., Henrique, T., & Tajara, E. H. (2015) · Disease Markers · doi:10.1155/2015/946572 · Cited by 72
“One of the most useful cancer biomarkers in clinical medicine is kallikrein-related peptidase 3 or PSA, which is a member of this family (reviewed by [7]), and there is evidence that other KLKs are also deregulated in cancer and other diseases [4, 39–147] as summarized in Table 1.”
BackgroundPrice, G. W., Chadjichristos, C. E., Kavvadas, P., Tang, S. C. W., Yiu, W. H., Green, C. R., Potter, J. A., Siamantouras, E., Squires, P. E., & Hills, C. E. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00558-1 · Cited by 59
Self-citationDai, S., Ding, M., Liang, N., Li, Z., Li, D., Guan, L., & Liu, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-56263-8 · Cited by 49
Kong, X., Zhao, Y., Wang, X., Yu, Y., Meng, Y., Yan, G., Yu, M., Jiang, L., Wu, S., Wang, B., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110640 · Cited by 48
Hills, C. E., Price, G. W., Wall, M. J., Kaufmann, T. J., Tang, C.-W., Yiu, W. H., & Squires, P. E. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488185 · Cited by 47
Self-citationThe Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney
Ramani, K., Garg, A. V., Jawale, C. V., Conti, H. R., Whibley, N., Jackson, E. K., Shiva, S. S., Horne, W., Kolls, J. K., Gaffen, S. L., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005952 · Cited by 43
Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy
Krochmal, M., Kontostathi, G., Magalhães, P., Makridakis, M., Klein, J., Husi, H., Leierer, J., Mayer, G. J., Bascands, J., Denis, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15359-9 · Cited by 43
The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis
Lok, S. W. Y., Yiu, W. H., Li, H., Xue, R., Zou, Y., Ли, Б., Chan, K. W., Chan, L. Y. Y., Leung, J. C. K., Lai, K. N., et al. (2020) · Clinical Science · doi:10.1042/cs20200923 · Cited by 38
Self-citationLi, H., Yuan, Y., Zhang, Y., He, Q., Rong-juan, X., Ge, F., & Wu, C. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5570 · Cited by 38
“The primer sequences used were as follows: IL-6, forward 5'-ATG AAC TCC TTC TCC ACA AG -3' and reverse 5'-TGT CAA TTC GTT CTG AAG AG-3' (26); IL-8, forward 5'-GTG CAG TTT TGC CAA GGAGT-3' and reverse 5'-TAA TTT CTG TGT TGG CGCAG-3' (26); IL-10, forward 5'-CTT CGA GAT CTC CGA GAT GCC TTC-3' reverse 5'-ATT CTT CAC CTG C…”
Gordon, W. E., Baek, S., Nguyen, H. P., Kuo, Y., Bradley, R., Fong, S., Kim, N., Galazyuk, A. V., Lee, I., Ingala, M. R., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44186-y · Cited by 37
“Amongst these genes was kallikrein 1 ( KLK1 ), an endocrine-responsive gene that is induced by high glucose 73 , that was found to be highly expressed in Jamaican fruit bat type A intercalated cells but not in big brown bats (Fig.”
Kagota, S., Maruyama, K., & McGuire, J. J. (2016) · BioMed Research International · doi:10.1155/2016/3130496 · Cited by 34
“In the second theme, researchers have focused onmodels residing primarily outside of the endothelial cell domain [54–60, 62–67].”
BackgroundResultInfluentialImplication of the MAPK Signalling Pathway in the Pathogenesis of Diabetic Nephropathy
Barros, J. B. D. S., Santos, R. D. S., & Reis, Â. A. D. S. (2019) · EMJ Diabetes · doi:10.33590/emjdiabet/10311665 · Cited by 31
Oda, Y., Nishi, H., & Nangaku, M. (2023) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2023.151431 · Cited by 30
Kallikrein-related peptidases in lung diseases
Bonda, W. L. M., Iochmann, S., Magnen, M., Courty, Y., & Reverdiau, P. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0114 · Cited by 30
Protease–activated receptor 2 exacerbates adenine–induced renal tubulointerstitial injury in mice
Hayashi, S., Oe, Y., Fushima, T., Sato, E., Satō, H., Ito, S., & Takahashi, N. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.108 · Cited by 30
TLR2–MyD88–NF-κB pathway is involved in tubulointerstitial inflammation caused by proteinuria
Ding, L., Liu, D., Xu, M., Wu, M., Liu, H., Tang, R., Ma, K., Chen, P.-S., & Liu, B. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.10.014 · Cited by 28
Diabetic Nephropathy and Proximal Tubular Damage
Tang, S. C. W., Yiu, W. H., Lin, M. Y., & Lai, K. N. (2015) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2014.10.020 · Cited by 26
Self-citationPilot GWAS of caries in African-Americans shows genetic heterogeneity
Orlova, E., Carlson, J. C., Lee, M. K., Feingold, E., McNeil, D. W., Crout, R. J., Weyant, R. J., Marazita, M. L., & Shaffer, J. R. (2019) · BMC Oral Health · doi:10.1186/s12903-019-0904-4 · Cited by 21
Yan, X., Zhang, X., Li, H., Zou, Y., Lu, W., Zhan, M., Liang, Z., Zhuang, H., Ran, X., Ma, G., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00267 · Cited by 17
Zou, X., Zhang, X., Liu, X., Li, R., Wang, M., Wu, W., Sui, Y., & Zhao, H. (2015) · Journal of Diabetes Research · doi:10.1155/2015/310645 · Cited by 15
“A recent experimental study showed the tissue kallikrein mediated proinflammatory pathways and activation of proteaseactivated receptor-4 in proximal tubular epithelial cells [41].”
BackgroundKLK15 alters connective tissues in hypermobile Ehlers-Danlos syndrome
Gensemer, C., Petrucci, T., Beck, T. C., Daylor, V., Griggs, M., Griggs, C., Weintraub, A., Byerly, K., Guo, L., Morningstar, J. E., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113343 · Cited by 14
“40,41 The convergence of autoimmunity, mast cell activation, and autonomic dysfunction, hallmarks of POTS, MCAS, and rheumato-logic overlap syndromes frequently seen in hEDS, suggests a shared upstream pathological mechanism potentially linked to the KLK system.”
Boumali, R., Urli, L., Naïm, M., Soualmia, F., Kinugawa, K., Petropoulos, I., & Amri, C. E. (2024) · Biochimie · doi:10.1016/j.biochi.2024.04.001 · Cited by 13
Hoevenaar, M., Goossens, D., & Roorda, J. (2020) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320320979097 · Cited by 12
Sabir, N., Hussain, T. A., Liao, Y., Wang, J., Song, Y., Shahid, M. S., Cheng, G., Mangi, M. H., Yao, J., Yang, L., et al. (2019) · Cells · doi:10.3390/cells8050415 · Cited by 12
Serine proteases and protease-activated receptors signaling in the kidney
Fedoriuk, M., Stefanenko, M., Bohovyk, R., Semenikhina, M., Lipschutz, J. H., Staruschenko, A., & Palygin, O. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00143.2025 · Cited by 11
Shin, S. D., Boadi, E. A., Shah, S., Ezell, M., Li, P., & Bandyopadhyay, B. C. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109853 · Cited by 11
Chinese medicines in the treatment of experimental diabetic nephropathy
Liu, J., Chen, X., Tang, S. C. W., Sze, S. C. W., Feng, Y., Lee, C., & Zhang, K. Y. (2016) · Chinese Medicine · doi:10.1186/s13020-016-0075-z · Cited by 11
“The early stage of DN is characterized by hyperfunction and hypertrophy arising from oxidative stress and inflammation [3, 36, 37].”
BackgroundSelf-citationChymotrypsin and Trypsin Inhibitory Activity of Some Medicinal Plants Collected from Rize (Türkiye)
Günbatan, T., Sucu, M., Gökbulut, A., DİLMAÇ, E., & Gürbüz, İ. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202301879 · Cited by 9
Role of protease-activated receptor 4 in mouse models of acute and chronic kidney injury
Erreger, K., Cao, S., Pan, Y., Jiang, M., Zhang, M., Harris, R. C., & Hamm, H. E. (2023) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00162.2023 · Cited by 7
Aji, K., Aikebaier, A., Abula, A., & Song, G. L. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1440774 · Cited by 6
Screening Study on Serine Protease Inhibitory Activity of 10 Plant Species
Günbatan, T., DİLMAÇ, E., Gökbulut, A., Sucu, M., & Gürbüz, İ. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402776 · Cited by 5
Kallikrein–kinin system as a potential target for the treatment of intervertebral disc degeneration
Lu, T., Zhu, W., Yang, F., Zhu, K., Ren, J., Zhu, H., Ye, B., Sun, F., Zhang, W., & Qiu, X. (2025) · European journal of medical research · doi:10.1186/s40001-025-03341-5 · Cited by 4
“In addition, KLK1 was upregulated under high glucose conditions, and receptor blocking by specific antagonists activated the p42/44 and p38 MAPK signaling pathways, attenuating the production of inflammatory factors IL-8 and IL-6 stimulated by KLK1, respectively [26].”
Ruan, H., Ran, X., Xu, T., Li, D., Luo, F., Li, S., Wang, D. W., & Zhang, Q. (2025) · MedComm · doi:10.1002/mco2.70506 · Cited by 3
Petreski, T., Gradišnik, L., Varda, L., Kovačič, P., Dolenšek, J., Stožer, A., Bevc, S., & Maver, U. (2025) · Journal of Xenobiotics · doi:10.3390/jox15020052 · Cited by 3
“However, most studies that report using PTECs rely on either commercial cell lines or have isolated their cells from nephrectomy samples or post-mortem [46,47].”
The Ontogeny of Mouse Salivary Gland Macrophages Is Distinct between Sexes
Zhao, Q., Pan, S., Jaiswal, J., Zhang, L., Wang, L.-T., Chang, E., Shahsavari, A., Zhang, Y., Yu, V., Zheng, R., et al. (2026) · Journal of Dental Research · doi:10.1177/00220345251411907 · Cited by 3
“Among other female-biased genes, estrogen target genes Klk1 and Hspa1a/1b showed context-dependent pro-or anti-inflammatory activities (Yiu et al 2014); Fkbp5 and Lgals3 were proinflammatory (Dragomir et al 2012; Jantaruk et al 2017); and acini-abundant Scgb2b26 suggested higher phagocytosis (Fig.”
Analysis of IGHA1 and other salivary proteins post half marathon in female participants
Maruyama, Y., Seki, T., Ando, S., Tanabe, H., & Mori, H. (2023) · PeerJ · doi:10.7717/peerj.15075 · Cited by 3
“KLK1 is a serine protease that is a component of the kallikrein kinin system (KKS) ( Yiu et al., 2014 ).”
Bu, X.-Y., Tan, H., Wang, A. M., Wei, M.-T., Pan, S., Gao, J.-Z., Li, Y., Qian, G., Chen, Z., Ye, C., et al. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i26.107044 · Cited by 2
“The Klk1 -high Paneth1 subset may play a more active role in pathogen defense and local inflammation regulation, potentially cooperating with BMP7 signaling[39,40].”
Tryptase-like proteases: A novel perspective for fibrosis
Zhang, H., Li, N., Li, M.-Q., Chen, Y.-N., Yin, S., Chen, T., Xu, N.-N., Liu, W., Xu, Y.-Q., Wang, H., et al. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123970 · Cited by 1
Khan, Z., Mauer, M. S., & Caramori, M. L. (2023) · Endocrines · doi:10.3390/endocrines4030039 · Cited by 1
“Moreover, recombinant KLK1 can stimulate the production of inflammatory cytokines in PTEC through activation of p42/44 and p38 MAPK signaling pathways [23].”
BackgroundDai, S., Yin, B., Wang, H., & Zhang, X. (2024) · Angiology · doi:10.1177/00033197241232165 · Cited by 1
“41 We hypothesized that the varying balance between Ang-II and KLK1 in early versus late stages of atherosclerotic lesions may account for the differential impact of endogenous KLK1 on STEMI.”
Maseko, T. G. (2019) · ResearchSpace (University of KwaZulu-Natal) · Cited by 1
Stefanini, A. C. B. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2019.tde-14082019-103138
Kallikrein in the Interstitial Space
(2016) · Protein science series · doi:10.1201/9781315374307-7
Webb, E. M., Cao, S., Pan, Y., Zhang, M., Harris, R. C., Boutaud, O. G., Bouchard, J. L., Jones, C. K., Lindsley, C. W., & Hamm, H. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.27.714572
Metadata
- Authors
- Yiu, W. H., Wong, D. W. L., Chan, L. Y. Y., Leung, J. C. K., Chan, K. W., Lan, H. Y., Lai, K. N., & Tang, S. C. W.
- Affiliations
- Queen Mary Hospital (CN)
- Chinese University of Hong Kong (HK)
- Corresponding author
- Tang, Sydney C. W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-02-21
- Volume
- 9
- Issue
- 2
- Pages
- e88894
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3931644
- OpenAlex
- W2038515422
- Cited by
- 50
- References
- 53
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 7 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 5 · 2018: 1 · 2017: 1 · 2016: 7 · 2015: 6
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion, cc-by-nc-nd)
- Funders
- American Society of Nephrology
- University of Hong Kong
- National Key Research and Development Program of China (2012CB517600, 2012CB517606)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- tissue kallikrein, KLK1, diabetic nephropathy, proximal tubular epithelial cells, PAR4, kallikrein-kinin system, inflammation, high glucose, advanced glycation end products, MAPK signaling, interleukin-8, ICAM-1, interleukin-6, MCP-1, connective tissue growth factor, type IV collagen, renal fibrosis, calcium mobilization, therapeutic target
- MeSH terms
- Analysis of Variance, Calcium, Cells, Cultured, Diabetes Mellitus, Enzyme-Linked Immunosorbent Assay, Epithelial Cells, Humans, Immunohistochemistry, Inflammation, Kidney Tubules, Proximal, Blotting, Western, Signal Transduction, Cytokines, Interleukin-8, DNA Primers, Receptors, Thrombin, Tissue Kallikreins, RNA Interference, RNA, Small Interfering, Receptors, Proteinase-Activated, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.